Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.381%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 425.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options, PDMR Dealings & TVR

23 Dec 2022 08:30

RNS Number : 8915K
Avingtrans PLC
23 December 2022
 

23 December 2022

Avingtrans Plc

("Avingtrans", the "Company", or the "Group")

Exercise of Options, PDMR Dealings and Total Voting Rights

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces transactions involving its shares by certain PDMRs (including Executive Directors), and other staff members pursuant to the Company's Executive Shared Ownership Plan ("ExSOP") and Company Share Option Plan ("CSOP").

ExSOP

On 21 December 2022, the Company was notified of the exercise of certain option awards over ordinary shares of 5p each in the Company ("Ordinary Shares") in the ExSOP. The option awards were issued to the PDMRs in November 2018 and December 2019. The vesting criteria, being growth in adjusted basic earnings per share equalling the increase in the retail price index over the three year vesting period, has been achieved.

Details of the exercise of options by PDMRs, together with the subsequent beneficial holdings of each individual following the transactions are set out below:

PDMR / Role

ExSOP Plan

ExSOP options exercised

Number of Ordinary Shares which have vested to each Director

Beneficial interest in Ordinary Shares following the transaction1

Percentage of Enlarged Total Voting Rights held following exercise

Austen Adams (MD, Process Solutions & Rotating Equipment)

FY 2019

100,000

33,860

175,607

0.54%

Steven King (CFO)

FY 2018

100,000

45,503

406,938

1.26%

Steve McQuillan (CEO)

FY 2018

115,000

52,328

468,987

1.45%

1Including Persons Closely Associated

The ExSOP options exercised at a price of 440p per option, being the closing mid-market price on 21 December 2022.

The exercise of the awards under the ExSOP have been satisfied by the reallocation of 131,691 existing Ordinary Shares already in the employees' share trust.

CSOP Exercise

In addition to the ExSOP exercise, on 21 December 2022, the Company was notified that certain employees exercised a total of 109,000 options over Ordinary Shares pursuant to the Company's FY 2019 Approved CSOP and FY2019 Unapproved CSOP (together, the "CSOP Options").

Issue of Equity

Exercise of the CSOP Options have been satisfied through the issue of 109,000 new Ordinary Shares.

Application has been made for admission to trading on AIM for the 109,000 new Ordinary Shares ("Admission"). It is expected that Admission will become effective on 30 December 2022.

Total Voting Rights

Following the issue of the 109,000 new Ordinary Shares, the Company will have a total of 32,250,445 Ordinary Shares in issue. The Company does not hold any shares in Treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Avingtrans plc

01354 692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

 

Singer Capital Markets (Nominated Adviser and Broker)

02074 963000

Shaun Dobson / Alex Bond / Oliver Platts (Investment Banking)

 

 

IFC Advisory (Financial PR)

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

 

 

About Avingtrans plc: 

 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

 

Business units

 

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Rochester Hills, Michigan, USA

Energy Steel, part of the Engineered Pumps and Motors Division of Avingtrans plc, has been serving the nuclear power industry since 1982 with capabilities in equipment fabrication, material supply, precision machining, engineering, and repair services. Through strategic OEM partnerships, it also provides solutions for obsolete nuclear components and support for the most complex projects. 

 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

 

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

 

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. 

 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Steve McQuillan

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

ExSOP Option Awards over Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Exercise of Options under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

440p

115,000

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Steve McQuillan

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Award of Ordinary Shares which have vested under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

52,328

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stephen King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CFO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

ExSOP Option Awards over Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Exercise of options under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

440p

100,000

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stephen King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CFO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Award of Ordinary Shares which have vested under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

45,503

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Austen Adams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

MD, Process Solutions & Rotating Equipment

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

ExSOP Option Awards over Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Exercise of options under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

440p

100,000

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Austen Adams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

MD, Process Solutions & Rotating Equipment

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Award of Ordinary Shares which have vested under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

33,860

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFLTFDLVFIF
Date   Source Headline
19th Aug 20117:00 amPRNNotice of Results
9th May 20119:00 amPRNHolding in Company
9th Mar 20117:00 amPRNTR-1:Notification of Major Interest in Shares
21st Feb 20117:00 amPRNGBP5m Contract Extension for Aerospace Division
9th Feb 20117:00 amRNSInterim Statement
17th Jan 20117:01 amPRNEUR 2.2m Contract Win
17th Jan 20117:00 amPRNTrading Statement
8th Dec 20101:38 pmRNSCorrection-Director/PDMR Shareholding
8th Dec 201010:27 amRNSHolding(s) in Company
8th Dec 201010:25 amRNSDirector/PDMR Shareholding
9th Nov 201011:44 amRNSHolding(s) in Company
13th Oct 201011:35 amRNSResult of AGM 2010
24th Sep 20101:00 pmPRNDirector/PDMR Shareholding
24th Sep 201012:09 pmPRNGrant of Options
8th Sep 20107:00 amPRNFinal Results
7th Sep 20107:00 amPRNAerospace Contract Wins
6th Sep 20107:00 amPRNContract Win
26th Jul 20107:00 amPRNChange of Adviser
7th Jul 201010:13 amPRNHolding(s) in Company
2nd Jul 20107:00 amRNSContract Win
15th Jun 20107:00 amPRNTrading Update
1st Apr 20107:00 amPRNGBP8m Contract Win and Award Win
19th Mar 20102:52 pmPRNDirector/PDMR Shareholding
19th Mar 20107:00 amPRNTrading Statement
17th Mar 20107:30 amPRNHolding(s) in Company
18th Feb 201011:28 amPRNHolding(s) in Company
10th Feb 20102:59 pmPRNDirector/PDMR Shareholding
10th Feb 20107:00 amPRNHalf-yearly Report
27th Jan 20107:00 amPRNContract Win - Aerospace Division
15th Oct 200910:56 amPRNResult of AGM
6th Oct 20097:00 amRNSNew Contract Award
9th Sep 20097:03 amPRNDirectorate Change
9th Sep 20097:00 amPRNFinal Results
11th Aug 20097:00 amRNSContract Extension
5th Aug 20099:14 amRNSNotice of Results
17th Jul 20093:01 pmRNSSettlement of Claim
8th Jul 20093:10 pmRNSGrant of Options
7th Jul 20095:03 pmRNSTotal Voting Rights
8th Jun 200912:48 pmRNSHolding(s) in Company
29th May 20097:00 amRNSAdditional Listing
27th Apr 200910:48 amRNSDirector/PDMR Shareholding
10th Feb 20097:00 amRNSHalf Yearly Report
6th Feb 20097:00 amRNSNotice of Results
26th Jan 20097:00 amRNSContract Win
31st Oct 20087:00 amRNSTotal Voting Rights
22nd Oct 20083:13 pmRNSHolding(s) in Company
22nd Oct 20083:07 pmRNSHolding(s) in Company
22nd Oct 20083:01 pmRNSHolding(s) in Company
22nd Oct 20082:18 pmRNSHolding(s) in Company
20th Oct 20083:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.